August 2018 FDA Recall Atorvastatin Calcium by Dr. Reddy's Laboratories, Inc.
D-1079-2018 - Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.

This Class III drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on August 2, 2018 for the product Atorvastatin Calcium. The FDA reported the reason for recall as failed impurities/degradation specifications - oos was observed for atv cyclo fp impurity and total degradation impurities tested at the 18 month stability time point in atorvastatin calcium tablets 40 mg 500 tablets.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1079-2018

Reason for Recall
Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.
Initiated
08-02-2018
Reported
08-22-2018
Quantity
2280 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Dr. Reddy's Laboratories, Inc.
Atorvastatin Calcium tablets, 40 mg, 500-count bottle, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 India, NDC 55111-123-05

Batch or Lot Expiration Information

Lot# T60045